Human Microbiome Modulators Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: H1D7804B47E6EN
Market Monitor Global

Abstracts

The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.

This report contains market size and forecasts of Human Microbiome Modulators in Global, including the following market information:

Global Human Microbiome Modulators Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Human Microbiome Modulators market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Probiotics and Creams Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Microbiome Modulators companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Microbiome Modulators Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Modulators Market Segment Percentages, by Type, 2021 (%)

• Probiotics and Creams
• Prebiotics and Dietary Supplements
• Drugs

Global Human Microbiome Modulators Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Modulators Market Segment Percentages, by Application, 2021 (%)

• Digestive Health
• Immune Health
• Oral Health
• Others

Global Human Microbiome Modulators Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Human Microbiome Modulators Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Microbiome Modulators revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Human Microbiome Modulators revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• BioGaia
• Chr. Hansen Holding
• DowDuPont
• Ingredion
• ISOThrive
• Jarrow Formulas
• DSM
• Lallemand
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Microbiome Modulators Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Microbiome Modulators Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN MICROBIOME MODULATORS OVERALL MARKET SIZE

2.1 Global Human Microbiome Modulators Market Size: 2021 VS 2028
2.2 Global Human Microbiome Modulators Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Human Microbiome Modulators Players in Global Market
3.2 Top Global Human Microbiome Modulators Companies Ranked by Revenue
3.3 Global Human Microbiome Modulators Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Modulators Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Microbiome Modulators Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Modulators Players in Global Market
  3.6.1 List of Global Tier 1 Human Microbiome Modulators Companies
  3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Modulators Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Human Microbiome Modulators Market Size Markets, 2021 & 2028
  4.1.2 Probiotics and Creams
  4.1.3 Prebiotics and Dietary Supplements
  4.1.4 Drugs
4.2 By Type - Global Human Microbiome Modulators Revenue & Forecasts
  4.2.1 By Type - Global Human Microbiome Modulators Revenue, 2017-2022
  4.2.2 By Type - Global Human Microbiome Modulators Revenue, 2023-2028
  4.2.3 By Type - Global Human Microbiome Modulators Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Microbiome Modulators Market Size, 2021 & 2028
  5.1.2 Digestive Health
  5.1.3 Immune Health
  5.1.4 Oral Health
  5.1.5 Others
5.2 By Application - Global Human Microbiome Modulators Revenue & Forecasts
  5.2.1 By Application - Global Human Microbiome Modulators Revenue, 2017-2022
  5.2.2 By Application - Global Human Microbiome Modulators Revenue, 2023-2028
  5.2.3 By Application - Global Human Microbiome Modulators Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Microbiome Modulators Market Size, 2021 & 2028
6.2 By Region - Global Human Microbiome Modulators Revenue & Forecasts
  6.2.1 By Region - Global Human Microbiome Modulators Revenue, 2017-2022
  6.2.2 By Region - Global Human Microbiome Modulators Revenue, 2023-2028
  6.2.3 By Region - Global Human Microbiome Modulators Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Human Microbiome Modulators Revenue, 2017-2028
  6.3.2 US Human Microbiome Modulators Market Size, 2017-2028
  6.3.3 Canada Human Microbiome Modulators Market Size, 2017-2028
  6.3.4 Mexico Human Microbiome Modulators Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Human Microbiome Modulators Revenue, 2017-2028
  6.4.2 Germany Human Microbiome Modulators Market Size, 2017-2028
  6.4.3 France Human Microbiome Modulators Market Size, 2017-2028
  6.4.4 U.K. Human Microbiome Modulators Market Size, 2017-2028
  6.4.5 Italy Human Microbiome Modulators Market Size, 2017-2028
  6.4.6 Russia Human Microbiome Modulators Market Size, 2017-2028
  6.4.7 Nordic Countries Human Microbiome Modulators Market Size, 2017-2028
  6.4.8 Benelux Human Microbiome Modulators Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Human Microbiome Modulators Revenue, 2017-2028
  6.5.2 China Human Microbiome Modulators Market Size, 2017-2028
  6.5.3 Japan Human Microbiome Modulators Market Size, 2017-2028
  6.5.4 South Korea Human Microbiome Modulators Market Size, 2017-2028
  6.5.5 Southeast Asia Human Microbiome Modulators Market Size, 2017-2028
  6.5.6 India Human Microbiome Modulators Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Human Microbiome Modulators Revenue, 2017-2028
  6.6.2 Brazil Human Microbiome Modulators Market Size, 2017-2028
  6.6.3 Argentina Human Microbiome Modulators Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Human Microbiome Modulators Revenue, 2017-2028
  6.7.2 Turkey Human Microbiome Modulators Market Size, 2017-2028
  6.7.3 Israel Human Microbiome Modulators Market Size, 2017-2028
  6.7.4 Saudi Arabia Human Microbiome Modulators Market Size, 2017-2028
  6.7.5 UAE Human Microbiome Modulators Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Human Microbiome Modulators Major Product Offerings
  7.1.4 Bayer Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 BioGaia
  7.2.1 BioGaia Corporate Summary
  7.2.2 BioGaia Business Overview
  7.2.3 BioGaia Human Microbiome Modulators Major Product Offerings
  7.2.4 BioGaia Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.2.5 BioGaia Key News
7.3 Chr. Hansen Holding
  7.3.1 Chr. Hansen Holding Corporate Summary
  7.3.2 Chr. Hansen Holding Business Overview
  7.3.3 Chr. Hansen Holding Human Microbiome Modulators Major Product Offerings
  7.3.4 Chr. Hansen Holding Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.3.5 Chr. Hansen Holding Key News
7.4 DowDuPont
  7.4.1 DowDuPont Corporate Summary
  7.4.2 DowDuPont Business Overview
  7.4.3 DowDuPont Human Microbiome Modulators Major Product Offerings
  7.4.4 DowDuPont Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.4.5 DowDuPont Key News
7.5 Ingredion
  7.5.1 Ingredion Corporate Summary
  7.5.2 Ingredion Business Overview
  7.5.3 Ingredion Human Microbiome Modulators Major Product Offerings
  7.5.4 Ingredion Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.5.5 Ingredion Key News
7.6 ISOThrive
  7.6.1 ISOThrive Corporate Summary
  7.6.2 ISOThrive Business Overview
  7.6.3 ISOThrive Human Microbiome Modulators Major Product Offerings
  7.6.4 ISOThrive Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.6.5 ISOThrive Key News
7.7 Jarrow Formulas
  7.7.1 Jarrow Formulas Corporate Summary
  7.7.2 Jarrow Formulas Business Overview
  7.7.3 Jarrow Formulas Human Microbiome Modulators Major Product Offerings
  7.7.4 Jarrow Formulas Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.7.5 Jarrow Formulas Key News
7.8 DSM
  7.8.1 DSM Corporate Summary
  7.8.2 DSM Business Overview
  7.8.3 DSM Human Microbiome Modulators Major Product Offerings
  7.8.4 DSM Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.8.5 DSM Key News
7.9 Lallemand
  7.9.1 Lallemand Corporate Summary
  7.9.2 Lallemand Business Overview
  7.9.3 Lallemand Human Microbiome Modulators Major Product Offerings
  7.9.4 Lallemand Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.9.5 Lallemand Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Human Microbiome Modulators Major Product Offerings
  7.10.4 Sanofi Human Microbiome Modulators Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Human Microbiome Modulators Market Opportunities & Trends in Global Market
Table 2. Human Microbiome Modulators Market Drivers in Global Market
Table 3. Human Microbiome Modulators Market Restraints in Global Market
Table 4. Key Players of Human Microbiome Modulators in Global Market
Table 5. Top Human Microbiome Modulators Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Microbiome Modulators Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Microbiome Modulators Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Microbiome Modulators Product Type
Table 9. List of Global Tier 1 Human Microbiome Modulators Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Microbiome Modulators Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Microbiome Modulators Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Microbiome Modulators Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Microbiome Modulators Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Human Microbiome Modulators Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Microbiome Modulators Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Microbiome Modulators Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Human Microbiome Modulators Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Microbiome Modulators Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Microbiome Modulators Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Microbiome Modulators Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Microbiome Modulators Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Microbiome Modulators Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Microbiome Modulators Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Microbiome Modulators Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Microbiome Modulators Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Microbiome Modulators Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Microbiome Modulators Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Microbiome Modulators Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Microbiome Modulators Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Human Microbiome Modulators Product Offerings
Table 32. Bayer Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 33. BioGaia Corporate Summary
Table 34. BioGaia Human Microbiome Modulators Product Offerings
Table 35. BioGaia Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 36. Chr. Hansen Holding Corporate Summary
Table 37. Chr. Hansen Holding Human Microbiome Modulators Product Offerings
Table 38. Chr. Hansen Holding Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 39. DowDuPont Corporate Summary
Table 40. DowDuPont Human Microbiome Modulators Product Offerings
Table 41. DowDuPont Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 42. Ingredion Corporate Summary
Table 43. Ingredion Human Microbiome Modulators Product Offerings
Table 44. Ingredion Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 45. ISOThrive Corporate Summary
Table 46. ISOThrive Human Microbiome Modulators Product Offerings
Table 47. ISOThrive Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 48. Jarrow Formulas Corporate Summary
Table 49. Jarrow Formulas Human Microbiome Modulators Product Offerings
Table 50. Jarrow Formulas Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 51. DSM Corporate Summary
Table 52. DSM Human Microbiome Modulators Product Offerings
Table 53. DSM Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 54. Lallemand Corporate Summary
Table 55. Lallemand Human Microbiome Modulators Product Offerings
Table 56. Lallemand Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Human Microbiome Modulators Product Offerings
Table 59. Sanofi Human Microbiome Modulators Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Human Microbiome Modulators Segment by Type in 2021
Figure 2. Human Microbiome Modulators Segment by Application in 2021
Figure 3. Global Human Microbiome Modulators Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Microbiome Modulators Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Microbiome Modulators Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2021
Figure 8. By Type - Global Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 12. US Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 16. Germany Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 24. China Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 30. Brazil Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Microbiome Modulators Revenue Market Share, 2017-2028
Figure 33. Turkey Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Microbiome Modulators Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioGaia Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Chr. Hansen Holding Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DowDuPont Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ingredion Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ISOThrive Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Jarrow Formulas Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DSM Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lallemand Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Human Microbiome Modulators Revenue Year Over Year Growth (US$, Mn) & (2017-2022)